• Login
Tuesday, March 3, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Switzerland

Swiss researchers develop new drug to better combat iron deficiency

GenevaTimes by GenevaTimes
November 25, 2025
in Switzerland
Reading Time: 9 mins read
0
Swiss researchers develop new drug to better combat iron deficiency
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


ETH Zurich is leading the development of a new iron supplement.

ETH Zurich is leading the development of a new iron supplement.


Keystone / Christian Beutler





Generated with artificial intelligence.

Iron deficiency is a common problem, but iron supplements are often poorly absorbed. A product developed by the Swiss federal technology institute ETH Zurich hopes to offer a solution.


This content was published on


November 24, 2025 – 14:44

+Get the most important news from Switzerland in your inbox

Constant tiredness, headaches and a weakened immune system: worldwide, around two billion people suffer from iron deficiency; in Europe, one in five women is affected. Those who have to take iron tablets often suffer from side effects such as bloating, constipation or nausea.

“The challenge with iron supplements lies in providing bioavailable iron, that is, iron that can be absorbed by the body,” explains Raffaele Mezzenga from the Department of Health Sciences and Technology at ETH Zurich. He is leading the development of a new iron supplement.

+ Drugmakers are finally making medicine for women

This relies on a promising technology that aims to deliver iron in a highly absorbable form. Instead of conventional iron sulfate, it uses iron nanoparticles, together with plant proteins.

The result of the first clinical study shows that iron is absorbed almost twice as well compared to standard preparations, says ETH Zurich.

Lower dosage, fewer side effects

According to Pierre-Alexandre Krayenbühl, a doctor and iron specialist, the new ETH study is exciting. Common oral iron supplements are usually high dosage. “We have found that lower doses of iron lead to fewer side effects. We have also been able to demonstrate in studies that iron absorption is much more efficient this way,” he says.

More

There are thousands of videos about weight-loss drugs on social media that can be seen from anywhere in the world.

More


Medicine access

Swiss regulator and media clash over weight-loss drugs




This content was published on


Jan 21, 2025



Swissmedic has taken legal action against media for alleged unauthorised advertising of weight-loss drugs. Swiss media say this is censorship.  



Read more: Swiss regulator and media clash over weight-loss drugs


In the first clinical trial at ETH Zurich, the 52 participants experienced no side effects. However, long-term studies are still needed.

Potential for further dietary supplements

ETH Zurich has patented the technology. Researchers see the additional potential for combating other deficiencies. “We want to use this technology to go beyond iron and also produce supplements for zinc, iodine, and selenium,” says Mezzenga.

However, much work still needs to be done before the ETH Zurich iron supplement hits the market.

Adapted from German by DeepL/sb

We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.  

Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.

If you have any questions about how we work, write to us at english@swissinfo.ch

Articles in this story

Read More

Previous Post

‘Thoughtful Dialogue’ Needed On Ukraine

Next Post

Andrej Stojakovic sinks tough spin jumper, plus the foul, extending Illinois' lead over Texas-Rio Grande Valley

Next Post
Andrej Stojakovic sinks tough spin jumper, plus the foul, extending Illinois' lead over Texas-Rio Grande Valley

Andrej Stojakovic sinks tough spin jumper, plus the foul, extending Illinois' lead over Texas-Rio Grande Valley

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin